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Abstract 
Problem: Widespread opioid misuse has led to the opioid epidemic that claims 130 deaths 
per day due to an opioid overdose (CDC, 2018). The opioid epidemic has plagued the 
United States for three decades and has been considered a public health emergency since 
2017 (HHS, 2017). Rural communities are disproportionately affected by this problem and 
in 2014, the rate of opioid overdose deaths was 45% higher in rural communities 
(SAMHSA, 2018).  
Context: Medication-assisted treatment (MAT) is considered the most effective treatment 
for opioid dependence because it incorporates medication management and 
biopsychosocial supports (Jones et al., 2018). Retention in a MAT program is predictive 
of better health outcomes (Timko et al., 2016). However, there is a gap between opioid 
dependence treatment need and access to MAT services in rural communities due to 
limited resources (SAMHSA, 2018). The context for this project, within the particular 
setting, is based upon the gap analysis that identified limited access and a waiting list for 
MAT services at a community-based substance use disorder and recovery organization, 
Granite Wellness, within a rural Northern California community.  
Proposed Intervention: The proposed intervention is the expansion of MAT services at 
Granite Wellness.  
Proposed Outcome Measures: The project will evaluate the following outcome measures: 
the number of patients admitted to MAT services, the 3-month treatment retention rate, 
patient satisfaction, and staff satisfaction.  
Problem Description 
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Misuse of prescription and non-prescription opioids began in the 1990s (HHS, 
2019). Several events preceded and contributed to the eventual widespread misuse of 
opioids. Firstly, two small retrospective studies that were published in the 1980s 
reassured medical providers that it was safe to prescribe opioids more frequently (Jones 
et al., 2018). Secondly, pharmaceutical companies also aggressively marketed opioids as 
non-addictive (Jones et al., 2018). Thirdly, there was an increased emphasis on treating pain 
thoroughly when pain was added as the fifth vital sign (Scalpel, 2016). As a result, medical 
professionals began prescribing opioids more frequently and there was an increase in the 
number of people who were opioid-dependent (Jones et al., 2018). This population began to 
use illicit opioids more frequently if they were unable to get a sufficient opioid prescription 
(CDC, 2018). Consequently, in 2010, an increase in heroin overdose deaths was observed 
(CDC, 2018). Then, in 2013, an increase in overdose deaths due to synthetic opioids, particularly 
fentanyl, was observed (CDC, 2018).  
Opioid use disorder (OUD) increases an individual’s morbidity and mortality (Hser et al., 
2017). There is also a significant societal impact related to “disease transmission, crime and law 
enforcement costs, family distress, lost productivity, and increased health care utilization” 
(Timko, Schultz, Cucciare, Vittorio, & Garrison-Diehn, 2016, p. 2). In 2015, it was estimated 
that the total economic burden of the opioid crisis was $504 billion (Hagemeier, 2018). In the US 
in 2016, there were 64,000 deaths due to drug overdoses, of which 42,000 were due to opioids 
(Jones et al., 2018). The U.S. Department of Health and Human Services (HHS) classified the 
opioid epidemic as a public health emergency in 2017 (HHS, 2017).  
In response to this public health emergency, there were efforts to establish new pain 
management guidelines and to develop new pain management treatment modalities with a lower 
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abuse potential. The Drug Addiction Treatment Act of 2000 (DATA 2000) established a waiver 
that physicians could apply for in order to prescribe medications for the treatment of opioid 
dependence (Jones et al., 2018). Initially, physicians were only able to treat 30 patients, 
however, in 2006, they were able to apply for an increase to 100 patients after the first year of 
the waiver (Jones et al., 2018). Buprenorphine and the combination of buprenorphine plus 
naloxone were FDA-approved in 2002 which allowed waivered physicians to prescribe them for 
the treatment of opioid dependence (Jones et al., 2018). The Comprehensive Addiction and 
Recovery Act of 2016 (CARA) allowed NPs and PAs to apply for a buprenorphine waiver after 
completing 24 hours of training (SAMHSA, 2016). 
Treatment programs that incorporate both pharmacotherapy and biopsychosocial 
interventions have proven to be the most effective treatment for opioid dependence (Jones et al., 
2018). Medication-assisted treatment (MAT) is the preferred treatment delivery method because 
it incorporates medication, behavioral therapy, and psychosocial supports. It has been shown that 
retention in a MAT program correlates with better patient outcomes (Timko et al., 2016). 
According to SAMSHA, MAT programs have been shown to improve patient survival, increase 
retention in treatment, decrease illicit opiate use, decrease criminal activity, increase ability to 
secure and maintain employment, improve birth outcome for moms with OUD, decrease risk of 
contracting HIV and Hep C, and decrease risk of relapse (SAMHSA, 2015).  
This project will be implemented within a community-based substance use and recovery 
organization called Granite Wellness, located in Nevada County, a rural Northern California 
community. The population for the project is under-served, rural residents with opioid use 
disorder. 
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This problem relates to the setting for the project because substance abuse is assumed to 
be an urban problem, but in 2014, the rate of opioid overdose deaths was 45% higher in rural 
areas compared to urban areas (SAMHSA, 2018). Furthermore, due to limited resources in rural 
communities, residents are underserved when it comes to substance use disorder treatment 
(SAMHSA, 2018). Therefore, there is a need for the project, the expansion of MAT services at 
Granite Wellness, in order to provide the necessary treatment to address the high prevalence of 
opioid use disorder within this underserved, rural community. Currently, there is also a waiting 
list for MAT services at Granite Wellness because the need is greater than the available access.  
Available Knowledge  
The PICOT question is, in opioid use disorder (P), how does MAT (I) compared to 
standard treatment (C) affect treatment retention (O) within 12 months (T)? The summary of 
evidence is organized in an evaluation table in Figure 1. of Appendix A.  
Substance use disorders (SUD) are relapsing conditions that result in high utilization of 
various healthcare resources. Painter et al. (2018) looked at the inpatient utilization of patients 
with SUD, in order to determine effective, lower-cost treatment options. They performed a 
retrospective chart review of the Veterans Health Administration national database focusing on 
patients with SUD, patients with co-occurring SUD and mental illness (MI), and patients with 
co-occurring SUD and serious mental illness (SMI), and their utilization of inpatient services. 
They reported that SUD/SMI and SUD/MI patients were higher utilizers than SUD patients. 
They also determined that patients with SUD alone primarily utilized inpatient medical services, 
patients with SUD/SMI primarily utilized inpatient psychiatric services, and patients with 
SUD/MI utilized medical, psychiatric, and substance-related inpatient services. Based upon these 
findings, they recommended coordination of outpatient medical, psychiatric and SUD services, 
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and case management in order to comprehensively treat these patients and reduce their use of 
hospital services. This article is rated Level II and good quality according to the Johns Hopkins 
Nursing Evidence-Based Practice Appendix E Research Evidence Appraisal.  
The Nickasch, Lander, Marshalek, Dix & Sullivan (2017) article was a retrospective 
chart review to determine if the delivery format of group-based MAT, face-to-face versus 
telepsychiatry, had an impact on additional substance use, average time to achieve 30 and 90 
consecutive days of abstinence, and treatment retention rates at 90 and 365 days. The medical 
records review consisted of 100 patients in the MAT program under the care of the same 
psychiatrist and who received medication management either face-to-face or via video 
conference. Both groups also received face-to-face group therapy with the same structure and 
goals, but with different therapists. The researchers found no statistical difference between the 
face-to-face and telepsychiatry groups regarding any of the outcome measures. However, with a 
p-value of 0.09, the telepsychiatry tended toward significance in achieving abstinence more 
quickly than the face-to-face group. The authors attempted to control for confounding by limiting 
patients to those under the care of the same physician which resulted in a small sample size and 
low statistical power. This article showed that when MAT is combined with face-to-face group 
therapy, the medication management can be delivered either face-to-face or via video 
conference, without having an impact on additional substance use, average time to achieve 
abstinence, or treatment retention. Although this study did not have a large enough sample size 
or enough statistical power to show statistical significance, it is clinically significant and can 
guide practice. The article is rated Level II and good quality according to the Johns Hopkins 
Nursing Evidence-Based Practice Appendix E Research Evidence Appraisal.  
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The Hewell, Vasquez & Rivkin (2017) article was a qualitative study that aimed to 
explore patient perceptions about buprenorphine and MAT in order to illuminate barriers to 
treatment access and utilization, and to better inform health policy. The researchers gathered data 
in 2 focus groups and semi-structured interviews of participants who had either been enrolled in 
or were currently enrolled in a MAT program. Grounded theory was used to code the data. The 
researchers utilized an outside data analysis expert in order to reduce any researcher biases. The 
researchers identified and described the following factors and their influence on seeking, 
participating and completing treatment: individual and systemic factors, models of addiction and 
MAT, barriers and facilitators, and the road to recovery. Understanding patient perceptions about 
MAT can guide changes in individual provider-patient interactions, treatment delivery, and 
health policy to facilitate and support long-term recovery. All participants agreed that MAT 
should not be solely medication management, rather, it should incorporate some supportive 
treatment. The study is limited by its small sample size that lacked diversity; therefore, the 
findings cannot be generalized. The researchers reported that even though they had a small 
sample size, they were able to gather enough data to answer all of the research questions and 
they reached data saturation. One of the main benefits of this study is that it outlines patient 
perceptions on treatment options for the very important issue of opioid addiction that has a major 
impact on the individual and the greater community. The article is rated Level V & good quality 
Johns Hopkins Nursing Evidence-Based Practice Appendix E & F.  
The Truong et al. (2019) article was a qualitative study to identify treatment retention 
barriers for individuals with OUD who participated in a combined MAT and peer-support 
program. The researchers gathered data through in-depth, semi-structured individual interviews 
with clients and staff, and focus group discussions with current and past clients. They identified 
THE EXPANSION AND EVALUATION OF MAT 8 
that for individuals enrolled in a combined MAT and peer-support program, the barriers to 
treatment retention, and long-term recovery as an extension, include cravings and withdrawal 
symptoms, mental health issues, legal issues, stigma of medication, inflexible program 
requirements and employment issues. Addressing these barriers can change practice by helping 
to guide MAT protocols to make treatment more supportive. This study is limited by its small 
sample size and the findings are not generalizable. Researchers interacted with the participants 
prior to the study which may have resulted in some bias. A strength of this study is that both the 
staff and the clients agreed on the primary challenges to treatment retention in a MAT program. 
This article is rated as Level V & good quality according to the Johns Hopkins Nursing 
Evidence-Based Practice Appendix E & F.  
Rationale 
One of the frameworks that underpins the project is the Health Belief Model (HBM). The 
HBM states that people are likely to engage in a health behavior change if they believe they are 
susceptible to a condition, the condition is severe, they can reduce the likelihood or severity of 
the condition by acting, there are benefits to acting, and the perceived barriers can be overcome 
(Glanz, Rimer, & Viswanath, 2015). An example of perceived susceptibility is: according to 
National Safety Council “Injury Facts”, people are more likely to die from an opioid overdose 
than from a motor vehicle accident (National Safety Council, 2019). An example of perceived 
severity is: people with OUD have a higher risk of death (Hser et al., 2017). An example of 
perceived threat is: according to the CDC, 130 Americans die every day from an opioid overdose 
(CDC, 2018). An example of perceived benefits is: MAT is a proven, effective approach to treat 
opioid use disorder that consists of medication and behavioral therapy (SAMHSA, 2015). An 
example of perceived barriers is: many people with OUD report that they feel ashamed or 
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undeserving of care (McElrath & Joseph, 2018). An example of a cues to action is: give MAT a 
try even if other treatment options have not been effective because the MAT process approaches 
treatment differently by getting to know the patient, his/her preferences and values. An example 
of self-efficacy is: MAT programs advertise the positive health outcomes associated with 
treatment to motivate people that they can achieve those outcomes by participating in the 
treatment program as well.  
Social Network Theory (SNT) is a theoretical framework that will also guide the project. 
SNT has three components: network environment, position in a network, and the effect of 
a networks structure and characteristics on performance (Glanz, Rimer, & Viswanath, 
2015). The first component describes how an individual’s actions are based upon one’s network 
environment; people tend to associate with people who are similar to them and that is called 
homophily (Glanz, Rimer, & Viswanath, 2015). The second component describes how a 
person’s position in a network influences his or her behavior (Glanz, Rimer, & Viswanath, 
2015). The third component describes how networks have structure and how network 
characteristics influence system performance (Glanz, Rimer, & Viswanath, 2015). This 
framework describes how social networks, i.e. a MAT program, influences one’s health-related 
behaviors, i.e. treatment retention. SNT predicts that an individual, surrounded by people in 
recovery, is more likely to engage in a recovery program as a result of homophily and influence.   
Specific Aims 
The purpose of this project is to improve health outcomes for patients with opioid use 
disorder in an underserved rural community in northern California by increasing access to 
medication assisted therapy (MAT) and evaluating factors that affect treatment retention. The 
AIM statement is: By January 2021, Granite Wellness Grass Valley Campus will expand and 
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evaluate Nurse-Managed Community-based Medication Assisted Treatment Services for an 
Underserved Rural Northern California Community to increase access to and retention in 
treatment for opioid use disorder. 
Methods 
Context 
 Contextual elements that are considered important are the key stakeholders. They include 
the opioid addicts, families/friends of the addicts, Granite Wellness employees, and the Nevada 
County community. The opioid addict role in this issue is working through a chronic, relapsing 
condition. The family/friend role in this issue is to provide support. The medical provider role is 
to be willing and able to address addiction, to engage in continuing education, and to facilitate 
the MAT program. The administrative and support staff role is to promote, support, and to 
participate in the facilitation of the MAT program. The Nevada County community role is to 
buy-in to MAT as an effective treatment for a serious public health problem and to provide 
funding in support of the MAT program and its expansion. 
Proposed Intervention 
The DNP student will begin by meeting with key stakeholders at Granite Wellness to 
understand the vision, mission and goals for the MAT program. The DNP student will evaluate 
the MAT services at Granite Wellness as developed and implemented by a previous DNP 
student. The initial evaluation will serve as baseline data and will assess: the current practices, 
the number of patients admitted to the program, the 3-month treatment retention rate, patient 
satisfaction surveys, and staff satisfaction surveys. The DNP student will schedule a follow-up 
meeting with key stakeholders to present the baseline data findings. The DNP student will assist 
in the expansion of MAT services as the buprenorphine waivered providers are able to increase 
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their patient load from 30 to 100 patients, per the waiver regulations. The DNP student will assist 
in writing new MAT protocols that account for the increased workflow. The DNP student will 
evaluate the aforementioned outcome measures 3-months after the expansion of MAT services. 
The DNP student will present the findings of this DNP project to the key stakeholders at Granite 
Wellness. 
There is a significant gap in the literature regarding MAT. In searching the databases, 
there were some articles in CINAHL, PubMed, Scopus, PsycINFO, and Joanna Briggs. There are 
opioid abuse and dependence treatment guidelines in Dynamed, but there are no specific 
guidelines for MAT. There were no systematic reviews on MAT in Cochrane.  
MAT is not a particularly new treatment concept, but it has become more well-known 
because of the opioid epidemic. The demand for access to MAT programs has increased 
substantially, but there is not a lot of research on the specifics of this treatment option, 
particularly regarding delivery format. In fact, there are no standardized guidelines or protocols 
for MAT programs; some programs are face-to-face, some are via telehealth, some are 
individual-based, some are group-based, etc. It seems that the research on MAT programs cannot 
keep up with the opioid epidemic. Rather than wait on large-scale studies to provide statistically 
significant results and evidence-based guidelines, MAT programs are sprouting up based upon 
clinically significant data and evolving in response to better meet the needs of their specific 
patient populations. MAT programs are producing practice-based evidence that will lead to the 
development of standardized, evidence-based practices.   
As mentioned earlier,  MAT increases retention in treatment and reduces opioid use, 
risky behaviors and mortality (Jones, Campopiano, Baldwin, & McCance-Katz, 2015). There is a 
significant gap between the need for opioid dependence treatment and access to MAT. 
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Nationally, the gap was estimated to be 1 million people in 2012, and that estimate was based 
upon every waivered physician maintaining a full patient load per their waiver capacity (Jones et 
al., 2015).  
Based upon the research, the gap analysis in Figure 2. of Appendix B, revealed that the 
desired state is access to MAT within this rural Northern California community in order to 
provide treatment for the high prevalence of opioid use disorder and improve health outcomes 
within this rural population. The current state is limited access to and a wait list for MAT 
services at Granite Wellness resulting in an underserved opioid-dependent population with a high 
incidence of opioid overdose deaths. The action needed is to increase access to MAT at Granite 
Wellness and to assess factors that facilitate treatment retention.  
The GANTT chart is in Figure 3. of Appendix C. The DNP student will meet with the 
DNP chair/clinical instructor in April 2020, during project implementation, and then in April to 
May 2021. The DNP recruit a doctorally prepared University of San Francisco (USF) faculty 
member as the second member of the committee in April 2020. The DNP student will maintain 
communication with the second committee member in June 2020 and January to May 2021. The 
DNP student will brief the MAT medical director and the Granite Wellness administration on the 
project between May and June 2020, and then provide a debrief in January and May 2021. The 
DNP student will brief the staff on the project during a staff meeting between May and June 
2020 and the debrief will be provided in May 2021. The project will be implemented between 
June 2020 and January 2021. The data will be compiled between November 2020 and January 
2021. The data analysis will be performed between November 2020 and February 2021. 
Recommendations will be made, based upon the data analysis, between February and May 2021.  
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The SWOT chart is in Figure 4 of Appendix D. The main strengths of this project is that 
MAT is the most effective treatment for opioid dependence (Jones et al., 2018). Another strength 
of this project is that it aims to increase access to MAT services at Granite Wellness through the 
expansion of a current program, rather than developing and implementing a new program. The 
expansion of MAT services at Granite Wellness will bridge the gap between demand for and 
access to opioid use disorder treatment in Nevada County, offer better opioid use disorder 
management in Nevada County, and improve health outcomes for people with opioid use 
disorder in Nevada County (Timko et al., 2016). Another strength of this project is that the 
Granite Wellness administration is on board and has bought in to the expansion of MAT 
services.  
The main weakness of this project is getting and maintaining buy-in from the 
buprenorphine-waivered providers. The waivered providers will be able to increase their patient 
load from 30 to 100 patients per the waiver regulations; their willingness to take on and maintain 
the increased workload will be a limiting factor in this project. Another weakness of this project  
is that the support staff will also experience an increase in workload. The Granite Wellness 
administration has approved the expansion of MAT services at the Grass Valley campus, but 
there are no plans to expand the physical space so that may pose a limitation to the services that 
are actually able to be provided. The final weakness to consider in this project is related to 
addiction as a chronic, relapsing condition and, as a corollary, providers and staff working in 
addiction medicine can experience strain and burnout.  
 The opportunity that this project offers is an effective means to address the opioid 
epidemic. The expansion of MAT services at Granite Wellness will have a direct impact on this 
public health issue within Nevada County, and over time, the downstream effects will be 
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observed on the national level. The expansion of MAT services has the potential to improve 
treatment retention rates by incorporating medication, behavioral therapy, and psychosocial 
supports (Jones et al., 2018). MAT can improve treatment retention rates which have been shown 
to correlate with better health outcomes (Timko et al., 2016). There is an opportunity for patient 
and staff satisfaction with the expansion of MAT services as a result of the improved retention 
rates and better health outcomes.  
 The threats to this project include patient buy-in. There is a stigma that people who are 
enrolled in MAT are not truly in recovery because one drug (i.e. buprenorphine) is being taken in 
the place of another (i.e. heroin). Stigma has been cited as one of the main barriers to both 
treatment access and retention (McElrath & Joseph, 2018). With any treatment plan, there is a 
risk that patients will be non-compliant. Although buprenorphine is considered to be “less-
addictive” as compared to methadone, there is still a risk of diversion. Lastly, there is a risk of 
relapse which would pose a threat to the success of this project.  
All in all, the strengths outweigh the weaknesses of this program. Based upon the SWOT 
analysis completed in Figure 4. of Appendix D, the program is feasible. 
The Work Breakdown Structure (WBS) Tree is in Figure 5. of Appendix E. The 
expansion of MAT services at Granite Wellness will occur in five phases: initiation, 
planning, execution, control and closeout.  
During the initiation phase, a gap analysis will be completed based upon a 
thorough literature review and a needs assessment specific to Granite Wellness in Grass 
Valley. The DNP student will meet with key stakeholders at Granite Wellness to understand the 
vision, mission and goals for the MAT program. The DNP student will evaluate the MAT 
services at Granite Wellness as developed and implemented by a previous DNP student. The 
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initial evaluation will serve as baseline data and will assess: the current practices, the number of 
patients admitted to the program, the 3-month treatment retention rate, patient satisfaction 
surveys, and staff satisfaction surveys. A project charter will be developed and submitted to 
the DNP chair for review. Upon approval, the project charter will be presented to Granite 
Wellness stakeholders for their approval.  
During the planning phase, the preliminary plan will be presented at a Granite 
Wellness staff meeting. The project team will be formed. There will be a project team 
kickoff meeting to present the preliminary plan and to get the team excited about the 
upcoming phases of the project. The project plan will be developed and finalized. The 
project plan will be submitted and approved by the DNP chair. Then, the project plan will 
be submitted and approved by Granite Wellness stakeholders.  
During the execution phase, there will be a project kickoff meeting to update all 
stakeholders on the project plan. Current MAT protocols will be verified and validated. 
The protocols will be updated, as needed, to align with the upcoming expansion. The data 
management system capabilities will be tested to verify its ability to manage an increase 
in data and to track data throughout this project for analysis. At this time, we will begin 
to advertise locally about the upcoming expansion of MAT services at Granite Wellness. 
In order to ease providers and staff in to this expansion, there will be a graduated 
expansion that will begin by increasing each provider’s buprenorphine empanelment from 
30 to 60 patients and then from 60 to 100 patients. Any initial “growing pains” that are 
observed during the initial graduated expansion, will be troubleshooted prior to the 
second graduated expansion. Additional training may need to be provided to the support 
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staff in order to assist them through this expansion. At this time, we will be ready to go 
live.  
During the control phase, project management will take place. There will be 
project status meetings. Risk management will be important especially because the 
expansion of these services is intended to reduce, both short-term and long-term, risks 
associated with opioid use disorder. The project management plan will be updated, as 
needed.  
During the closeout phase, data will be collected with a particular emphasis on the 
number of patients admitted to the program, the treatment retention rate, patient 
satisfaction surveys, and staff satisfaction surveys. Lessons learned will be documented. 
Data will be presented to Granite Wellness stakeholders. The prospectus will be 
submitted to the DNP chair. The final manuscript will be submitted to the DNP chair.  
The proposed budget is in Figure 6. of Appendix F. The DNP student will work at 
Granite Wellness 1 day/week for at least 6 months to assist in the expansion of MAT services 
and to evaluate the outcome measures 3-months after the expansion of MAT services. The 
estimated cost of those services is $75/hr., the average NP hourly rate in California x 192 hrs. = 
$14,400 (American Association of Nurse Practitioners, 2020). The estimated cost of copies of 
the satisfaction surveys and print outs from the electronic health record are $0.073/copy totaling 
approximately $10.00. 
The communication plan/matrix is in Figure 7. of Appendix G. For overall project 
planning, the DNP student will consult the project chair monthly and as needed via zoom, email 
and phone. For logistics, the DNP student will consult the project chair, MAT medical director & 
Granite Wellness administration prior to, during and post-intervention via face-to-face meetings 
THE EXPANSION AND EVALUATION OF MAT 17 
at Granite Wellness and email. The DNP student will give status updates to the project chair, 
MAT medical director & Granite Wellness administration as needed via email, zoom and face-
to-face. The DNP student will consult the project chair and Granite Wellness administration for 
any materials needed between April and June 2020, via email, phone, face-to-face. The project 
chair and Granite Wellness administration will be consulted to determine time, space, and 
technology requirements for the intervention between April and June 2020, via email, phone, and 
face-to-face.  
Proposed Outcome Measures 
This intervention will change practice because the expansion of MAT services at Granite 
Wellness will increase access to the preferred treatment delivery system for opioid use disorder 
and an increase in the treatment retention rate correlates to improved patient outcomes. The 
proposed outcome measures are the number of patients admitted to MAT services, 3-month 
treatment retention rate, patient satisfaction, and staff satisfaction. The effectiveness of this DNP 
project will be observed by an increase in the number of patients admitted to MAT services, a 
10% improvement in the 3-month treatment retention rate, and satisfactory answers on the 
patient and staff surveys.  
Proposed Analysis 
Excel will be utilized to collect and analyze the baseline and post-intervention data. 
Survey Monkey will be utilized to collect the pre and post satisfaction surveys. 
Ethical Considerations 
Patient privacy will be protected according to HIPAA policies. The project relates to the 
Jesuit value of Cura Personalis or care of the whole person: mind, body, and spirit because the 
premise of MAT is incorporating care of the whole person in to the treatment of the opioid use 
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disorder. (Ctzejanda, 2019). The project relates to the ANA Code of Ethics Provision 3: The 
nurse promotes, advocates for, and protects the rights, health, and safety of the patient because 
the MAT program at Granite Wellness is managed by nurses who promote, advocate for, and 
protect the rights, health and safety of the patients (American Nurses Association, 2015).  
Discussion 
Stigma has been identified as one of the main barriers to both treatment access and 
retention (McElrath & Joseph, 2018). The MAT approach aims to provides supportive, non-
judgmental, patient-centered treatment with an emphasis on shared-decision making between the 
medical provider and the patient so as to mitigate the effects of stigma.  
There are patient and provider barriers when it comes to MAT. Patient barriers include, 
but are not limited to, access to an available provider who is willing to prescribe, stigma as 
mentioned above, and the cost of treatment (Jones et al., 2015). This intervention aims to expand 
MAT services at Granite Wellness so that patients will have ready access to a provider who is 
willing to prescribe. Granite Wellness provides MAT services to anyone with an opioid use 
disorder regardless of their ability to pay to mitigate the cost of treatment as a barrier.  
Provider barriers include, but are not limited to, confidence in treating addiction, lack of 
professional and/or institutional support, and reimbursement issues (Jones et al., 2015). There is 
a free 24-hrs online training on medication-assisted treatment to increase provider confidence in 
treating addiction. The medical director at Granite Wellness provides mentorship and 
professional support. The Granite Wellness administration offers institutional support of the 
MAT program. Reimbursement issues are bigger than the scope of this project, unfortunately.  
Conclusions 
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The opioid epidemic has had significant, negative implications on individuals, as well as 
on society as a whole, within the United States. Medication-assisted treatment is widely accepted 
as the most effective treatment for opioid dependence. Rural communities are disproportionately 
affected by this problem and are underserved when it comes to treatment access. There is a 
significant gap between opioid dependence treatment need in Nevada County and MAT access at 
Granite Wellness. The potential short-term implications of this change in practice are increased 
access to MAT at Granite Wellness and improved treatment retention rates for the rural residents 
enrolled in MAT at Granite Wellness. The potential long-term implications of this change in 
practice are better health outcomes for residents of Nevada County with opioid use disorder and, 
on the macro level, an end to the opioid epidemic. 
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Appendix A 
Figure 1. Evaluation Table. 
Citation Purpose Research 
Design  
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Appendix B 




• Access to MAT within this rural Northern California 
community in order to provide treatment for the high 
prevalence of opioid use disorder and improve health 




• Limited access to and a wait list for MAT services at 
Granite Wellness resulting in an underserved opioid-




• Increase access to MAT at Granite Wellness and to assess 
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Appendix D 
Figure 4. SWOT Analysis.  
STRENGTHS 
MAT is the most effective treatment for 
opioid dependence.   
Increased access to MAT services at Granite 
Wellness through the expansion of a current 
practice. 
àbridge the gap between demand for and 
access to opioid use disorder treatment in 
Nevada County.  
àbetter opioid use disorder management in 
Nevada County. 
à improved health outcomes for people with 
opioid use disorder in Nevada County. 




Ability to get buprenorphine waivered 
providers buy-in to the increased workload in 
order to increase patient access to treatment.  
Increased responsibility for support staff.  
Physical space limitations.   
Addiction medicine provider and staff strain 





The expansion of these services is relevant to 
addressing the opioid epidemic.  
MAT can:  
àimprove treatment retention rates.  
àimprove health outcomes.  
àimprove patient satisfaction. 






Program buy-in by patients with opioid use 
disorder.  
Stigma that enrollment in MAT services 
means that they are not clean and sober.   
Treatment non-compliance.  
Diversion of buprenorphine.  
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Appendix E 
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by DNP Chair 
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Begin to Advertise the 
Expansion of Services 
1.3.5 
Start to Increase  
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Appendix F 
Figure 6. Proposed Budget.  




1 day per 
week x 6 
months 
Assist in the expansion of MAT services 
and evaluate the outcome measures 3-
months after the expansion of MAT 
services.  
$75/hr. x  
192 hrs. = 
$14,400. 
Supplies 1 day per 
week x 6 
months 
Copies of satisfaction surveys and print 
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Appendix G 
Figure 7. Communication Plan/Matrix.  
Information Consulted When How  Responsible 
Overall Project 
Planning 
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Status Updates DNP Chair, MAT 
Medical Director & 
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Intervention 
Materials 
DNP Chair & 
Granite Wellness 
Administration  










DNP Chair & 
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